Inhibition of Kir4.1 potassium channels by quinacrine

• DOI: 10.1016/j.brainres.2017.03.009
• Publication Date: 2017-03-11T06:19:38Z
• Authors: Leticia G. Marmol...; Iván A. Aréchiga-...; Meng Cui; Eloy G. Moreno-Ga...; Ricardo A. Navarr...; José A. Sánchez-C...; Tania Ferrer; Aldo A. Rodríguez...
• Keywords: 0301 basic medicine; Patch-Clamp Techniques; Potassium Channels; Rats; 3. Good health; 03 medical and health sciences; HEK293 Cells; Quinacrine; Astrocytes; Potassium; Animals; Humans; Potassium Channels, Inwardly Rectifying; Ion Channel Gating

Inwardly rectifying potassium (Kir) channels are expressed in many cell types and contribute to a wide range of physiological processes. Particularly, Kir4.1 channels are involved in the astroglial spatial potassium buffering. In this work, we examined the effects of the cationic amphiphilic drug quinacrine on Kir4.1 channels heterologously expressed in HEK293 cells, employing the patch clamp technique. Quinacrine inhibited the currents of Kir4.1 channels in a concentration and voltage dependent manner. In inside-out patches, quinacrine inhibited Kir4.1 channels with an IC50 value of 1.8±0.3μM and with extremely slow blocking and unblocking kinetics. Molecular modeling combined with mutagenesis studies suggested that quinacrine blocks Kir4.1 by plugging the central cavity of the channels, stabilized by the residues E158 and T128. Overall, this study shows that quinacrine blocks Kir4.1 channels, which would be expected to impact the potassium transport in several tissues.